J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02354-1. doi: 10.1016/j.jid.2025.07.030. Online ahead of print. NO ABSTRACT PMID:40850652 | DOI:10.1016/j.jid.2025.07.030
Clin Immunol. 2025 Aug 22:110588. doi: 10.1016/j.clim.2025.110588. Online ahead of print. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune
Osteoarthritis Cartilage. 2025 Aug 22:S1063-4584(25)01122-7. doi: 10.1016/j.joca.2025.08.011. Online ahead of print. ABSTRACT OBJECTIVE: Treatment of osteoarthritis (OA) remains limited to
J Immunol. 2025 Aug 24:vkaf211. doi: 10.1093/jimmun/vkaf211. Online ahead of print. ABSTRACT Sjögren syndrome-related interstitial lung disease (SS-ILD) is a
Curr Rheumatol Rev. 2025 Aug 15. doi: 10.2174/0115733971389117250807101431. Online ahead of print. ABSTRACT BACKGROUND: Integrative medicine, which combines complementary and
Int J Dermatol. 2025 Aug 24. doi: 10.1111/ijd.70024. Online ahead of print. ABSTRACT BACKGROUND: It is challenging to distinguish nail
J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7. ABSTRACT Natural killer (NK) cells are a crucial part of
Ann Rheum Dis. 2025 Aug 22:S0003-4967(25)04292-X. doi: 10.1016/j.ard.2025.07.019. Online ahead of print. ABSTRACT OBJECTIVES: Despite advances in rheumatoid arthritis (RA)
Ann Rheum Dis. 2025 Aug 22:S0003-4967(25)04294-3. doi: 10.1016/j.ard.2025.07.024. Online ahead of print. ABSTRACT OBJECTIVES: This study aims to analyse potential
Dig Liver Dis. 2025 Aug 22:S1590-8658(25)00957-0. doi: 10.1016/j.dld.2025.07.038. Online ahead of print. ABSTRACT BACKGROUND & AIM: The diagnosis of alcohol-associated
Ann Rheum Dis. 2025 Aug 22:S0003-4967(25)04289-X. doi: 10.1016/j.ard.2025.07.018. Online ahead of print. ABSTRACT OBJECTIVES: Study the efficacy and safety of
Ann Rheum Dis. 2025 Aug 22:S0003-4967(25)04295-5. doi: 10.1016/j.ard.2025.07.025. Online ahead of print. ABSTRACT A 52-year-old woman presented to the rheumatology
Osteoarthritis Cartilage. 2025 Aug 21:S1063-4584(25)01114-8. doi: 10.1016/j.joca.2025.08.004. Online ahead of print. ABSTRACT OBJECTIVE: This review provides an overview of the
Clin Immunol. 2025 Aug 21:110576. doi: 10.1016/j.clim.2025.110576. Online ahead of print. ABSTRACT Current serological markers for rheumatoid arthritis (RA) lack
Cell Genom. 2025 Aug 19:100978. doi: 10.1016/j.xgen.2025.100978. Online ahead of print. ABSTRACT Psoriasis vulgaris (PsV) is an immune-mediated inflammatory skin
Crit Rev Oncol Hematol. 2025 Aug 21:104913. doi: 10.1016/j.critrevonc.2025.104913. Online ahead of print. ABSTRACT This study critically examines the evolving
Osteoarthritis Cartilage. 2025 Aug 21:S1063-4584(25)01113-6. doi: 10.1016/j.joca.2025.08.003. Online ahead of print. ABSTRACT OBJECTIVE: Inflammatory mediators, including polyunsaturated fatty acids (PUFAs)
Aliment Pharmacol Ther. 2025 Aug 23. doi: 10.1111/apt.70311. Online ahead of print. NO ABSTRACT PMID:40848273 | DOI:10.1111/apt.70311
Respir Med Res. 2025 Aug 5;88:101195. doi: 10.1016/j.resmer.2025.101195. Online ahead of print. ABSTRACT BACKGROUND: Neutrophil extracellular traps (NETs) play a
Spectrochim Acta A Mol Biomol Spectrosc. 2025 Aug 18;345:126836. doi: 10.1016/j.saa.2025.126836. Online ahead of print. ABSTRACT In today’s medical diagnosis
Rheumatology (Oxford). 2025 Aug 23:keaf454. doi: 10.1093/rheumatology/keaf454. Online ahead of print. NO ABSTRACT PMID:40848249 | DOI:10.1093/rheumatology/keaf454
Cardiovasc Intervent Radiol. 2025 Aug 22. doi: 10.1007/s00270-025-04163-y. Online ahead of print. ABSTRACT PURPOSE: To evaluate one- and two-year outcomes
Neurol Res Pract. 2025 Aug 22;7(1):58. doi: 10.1186/s42466-025-00419-7. ABSTRACT BACKGROUND: Kappa free light chains (KFLC), a byproduct of immunoglobulin (Ig)
Reprod Health. 2025 Aug 22;22(1):149. doi: 10.1186/s12978-025-02095-x. ABSTRACT BACKGROUND: The purpose of the present study was to examine the association
Geriatr Gerontol Int. 2025 Aug 23. doi: 10.1111/ggi.70149. Online ahead of print. ABSTRACT AIM: The present study aimed to determine
Mod Rheumatol. 2025 Aug 23:roaf066. doi: 10.1093/mr/roaf066. Online ahead of print. ABSTRACT OBJECTIVES: With the introduction of anifrolumab to clinical
Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607-w. Online ahead of print. ABSTRACT In the largest meta-analysis of international cohorts to
